ESR1 and breast cancer: The molecular mechanisms driving BC pathogenesis have been extensively researched and categorized into three major subtypes (luminal, HER2-enriched, and triple-negative breast cancer) based on markers such as expression of estrogen receptor (ER) and progesterone receptor (PR)3.